BARR PHARMACEUTICALS INC 4
4 · BARR PHARMACEUTICALS INC · Filed Dec 29, 2008
Insider Transaction Report
Form 4
CHEFITZ HAROLD N
Director
Transactions
- Exercise/Conversion
Non-Qualified Stock Options
2008-12-23−10,000→ 0 totalExercise: $48.84From: 2007-11-09Exp: 2016-11-09→ Common Stock (10,000 underlying) - Disposition to Issuer
Common Stock
2008-12-23−26,250→ 0 total - Exercise/Conversion
Non-Qualified Stock Options
2008-12-23−7,500→ 0 totalExercise: $37.87From: 2005-10-28Exp: 2014-10-28→ Common Stock (7,500 underlying)
Footnotes (4)
- [F1]Disposed of pursuant to a merger agreement between Issuer and Teva Pharmaceutical Industries Ltd. in exchange for 16,464 shares of Teva Common Stock having a market value of $41.82 per share on the effective date of the merger and cash in the amount of $1,047,375.
- [F2]These options were assumed by Teva Pharmaceutical Industries Ltd pursuant to a merger agreement between the Issuer and Teva and replaced with options to purchase 11,859 shares of Teva Common Stock for $23.95 per share.
- [F3]These options were assumed by Teva Pharmaceutical Industries Ltd pursuant to a merger agreement between the Issuer and Teva and replaced with options to purchase 15,812 shares of Teva Common Stock for $30.89 per share.
- [F4]These options were assumed by Teva Pharmaceutical Industries Ltd pursuant to a merger agreement between the Issuer and Teva and replaced with options to purchase 15,812 shares of Teva Common Stock for $25.14 per share.